The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs

World Medical and Health Policy

Volumn 9, Issue 3, 2017, Pages 318-340

  Zadoretzky, Cathy ^a   McKnight, Courtney ^a   Bramson, Heidi ^a   Des Jarlais, Don ^a   Phillips, Maxine ^a   Hammer, Mark ^a   Cala, Mary Ellen ^a  

^a NONE

Author keywords

911 Good Samaritan Law; opioid overdose; overdose prevention

Indexed keywords

METHADONE;

911 GOOD SAMARITAN LAW; ADULT; ALTRUISM; ARTICLE; AWARENESS; BLACK PERSON; CANNABIS ADDICTION; CANNABIS USE; CAUCASIAN; COMMUNITY RETALIATION; CONTROLLED STUDY; CRIMINAL JUSTICE; CRIMINAL PENALTY; DEMOGRAPHY; DRUG USE; FATALITY; FEAR; FEMALE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEROIN DEPENDENCE; HISPANIC; HUMAN; INTERVIEW; INTOXICATION; LAW; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MIDDLE AGED; MISCELLANEOUS NAMED GROUPS; MIXED METHOD INTERVIEW; MORBIDITY; OPIOID OVERDOSE; OPIOID OVERDOSE PREVENTION PROGRAM; PEOPLE WHO INJECT DRUG; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SEX RATIO; SOCIAL ASPECT; SYRINGE EXCHANGE PROGRAM; THEMATIC ANALYSIS; YOUNG ADULT;

EID: 85028973573     PISSN: 21532028     EISSN: 19484682     Source Type: Journal    
DOI: 10.1002/wmh3.234     Document Type: Article

References (40)

1. Banta-Green, Caleb J., Patricia C. Kuszler, Phillip O. Coffin, and Jennifer A. Schoeppe. 2011. “Washington's 911 Good Samaritan Drug Overdose Law—Initial Evaluation Results.” Alcohol & Drug Abuse Institute, University of Washington [Online]. http://adai.uw.edu/pubs/infobriefs/ADAI-IB-2011-05.pdf. Accessed November 2011.
2. Bohnert, Amy S, Arijit Nandi, Melissa Tracy, Magdalena Cerdá, Kenneth J. Tardiv, David Vlahov, and Sandro Galea. 2011. “Policing and Risk of Overdose Mortality in Urban Neighborhoods.” Drug and Alcohol Dependence 113 (1): 62–68.
3. Carpenter, Matthew J., Mary Ann Chutuape, and Maxine Stitzer. 1998. “Heroin Snorters Versus Injectors: Comparison on Drug Use and Treatment Outcome in Age-Matched Samples.” Drug and Alcohol Dependence 53: 11–15.
4. Centers for Disease Control and Prevention (CDC). 2016. Injury Prevention and Control: Opioid Overdose: State Data [Online]. http://www.cdc.gov/drugoverdose/data/statedeaths.html. Accessed January 18, 2016.
5. Cuomo, Andrew. 2014. Governor Cuomo Signs Legislation to Combat Heroin, Opioid and Prescription Drug Abuse Epidemic [Online]. http://www.governor.ny.gov/press/06-23-2014-combat-drug-abuse. Accessed November 14, 2015.
6. Darke, Shane, and Joanne Ross. 2000. “Fatal Heroin Overdoses Resulting from Non-Injecting Routes of Administration, NSW, Australia, 1992–1996.” Addiction 95: 569–73.
7. Darke, Shane, Kate Hetherington, Joanne Ross, Michael Lynskey, and Maree Teesson. 2004. “Non-Injecting Routes of Administration Among Entrants to Three Treatment Modalities for Heroin Dependence.” Drug and Alcohol Review 23: 177–83.
8. Darke, Shane, and Wayne Hall. 1997. “The Distribution of Naloxone to Heroin Users.” Addiction 92 (9): 1195–99.
9. Darke, Shane, and Wayne Hall. 2003. “Heroin Overdose: Research and Evidence-Based Medicine.” Journal of Urban Health: Bulletin of the New York Academy of Medicine 80 (2): 189–200.
10. Davidson, Peter J., Rachel L. McLean, Alex H. Kral, Alice A. Gleghorn, Brian R. Edlin, and Andrew R. Moss. 2003. “Fatal Heroin-Related Overdose in San Francisco, 1997–2000: A Case for Targeted Intervention.” Journal of Urban Health: Bulletin of the New York Academy of Medicine 80 (2): 261–73.
11. Dedoose. 2014. Dedoose: Great Research Made Easy [Online]. http://www.dedoose.com/. Accessed November 15, 2014.
12. Division of Information and Statistics/New York State Department of Health (DIS/NYSDH). 2015. Annual Report of Vital Statistics: New York State 2013 [Online]. https://www.health.ny.gov/statistics/vital_statistics/docs/vital_statistics_annual_report_2013.pdf. Accessed December 8, 2015.
13. Drug Policy Alliance. 2016. Good Samaritan Laws: Preventing Overdose Deaths, Saving Lives [Online]. http://www.drugpolicy.org/sites/default/files/DPA_Fact%20Sheet_911%20Good%20Samaritan%20Laws_%28Feb.%202016%29.pdf. Accessed January 27, 2016.
14. Evans, Tristan I., Scott E. Hadland, Melissa A. Clark, Traci C. Green, and Brandon D.L. Marshall. 2016. “Factors Associated with Knowledge of a Good Samaritan Law Among Young Adults Who Use Prescription Opioids Non-Medically.” Harm Reduction Journal 13 (24): 1–6.
15. Glasgow, Reilly. 2014, March 25. Personal telephone communication with Reilly Glasgow, Director of Syringe Exchange and Holistic Services, Lower East Side Harm Reduction Center, New York, New York.
16. Guest, Greg, Kathleen M. MacQueen, and Emily E. Namey. 2011. Applied Thematic Analysis. London: Sage Publications.
17. Harm Reduction Coalition. 2014. Overview of Opioid Overdose Prevention Programs in New York State [Online]. http://www.carecoordination.org/documents/NYSoverdoseinitiative2.pdf. Accessed December 4, 2015.
18. Heller, Daniel I., and Sharon Stancliff. 2007. “Providing Naloxone to Substance Users for Secondary Administration to Reduce Overdose Mortality in New York City.” Public Health Reports 122: 393–97.
19. Kaléo. 2015. EVZIO™ (Naloxone HCl Injection) 0.04 Auto-Injector [Online]. http://www.evzio.com/hcp/. Accessed January 28, 2016.
20. Lankenau, Stephen E., Karla D. Wagner, Karol Silva, Aleksandar Kecojevic, Ellen Iverson, Miles McNeely, and Alex H. Kral. 2013. “Injection Drugs Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses.” Journal of Community Health 38: 133–41.
21. Lenton, Simon R., and Kenneth M. Hargreaves. 2000. “Should We Conduct a Trial of Distributing Naloxone to Heroin Users for Peer Administration to Prevent Fatal Overdose?” The Medical Journal of Australia, 173 (5): 160–63.
22. National Center for Health Statistics/Centers for Disease Control and Prevention (NCHS/CDC). 2015. Data Brief 190: Drug-Poisoning Deaths Involving Heroin: United States, 2000–2013 [Online]. http://www.cdc.gov/nchs/data/databriefs/db190_table.pdf#1. Accessed January 14, 2016.
23. National Library of Medicine. 2015, December 3. Naloxone Injection. Medline Plus. National Institutes of Health [Online]. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a612022.html. Accessed March 5, 2016.
24. New York Assembly Bill A2063 [Online]. 2011. https://www.nysenate.gov/legislation/bills/2011/a2063. Accessed March 5, 2016.
25. New York City Department of Health and Mental Hygiene. 2014, May 5. “Opioid Misuse in New York City.” Presented at New York City Department of Health & Mental Hygiene, Bureau of Alcohol & Drug Use Prevention Care & Treatment, Long Island City, New York.
26. New York City Department of Health and Mental Hygiene. 2015. “EPI Data Tables.” Unintentional Drug Poisoning (Overdose) Deaths Involving Opioids in New York City, 2011–2014 [Online]. 1–8. http://www.nyc.gov/html/doh/downloads/pdf/epi/datatable66.pdf. Accessed November 2, 2015.
27. New York State Department of Health. 2014. Directory of Registered Opioid Overdose Prevention Programs [Online]. http://www.health.ny.gov/diseases/aids/general/opioid_overdose_prevention/index.htm. Accessed January 12, 2016.
28. New York State Department of Health AIDS Institute. 2016. New York State Opioid Poisoning, Overdose and Prevention: 2015 Report to the Governor and NYS Legislature [Online]. http://www.health.ny.gov/diseases/aids/general/opioid_overdose_prevention/docs/annual_report2015.pdf. Accessed January 12, 2016.
29. New York State Division of Criminal Justice Services. 2013. Memorandum from Gina L. Bianchi, Deputy Commissioner and Counsel [Online]. http://www.nychiefs.org/media/Good_Samaritan_911_Law.pdf. Accessed November 4, 2015.
30. NOVA Research Company©. 2015. What Is QDS™? [Online]. http://www.novaresearch.com/products/QDS/whatIsQDS.cfm. Accessed November 6, 2015.
31. Piper, Tinka Markham, Sasha Rudenstine, Sharon Stancliff, Susan Sherman, Vijay Nandi, Allan Clear and Sandro Galea. 2007. “Overdose Prevention for Injection Drug Users: Lessons Learned from Naloxone Training and Distribution Programs in New York City. Harm Reduction Journal 4 (3). http://www.harmreductionjournal.com/content/4/1/3
32. Rudd, Rose A., Noah Aleshire, Jon E. Zibbell, and Matthew Gladden. 2016. “Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014.” Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR) 64 (50–51): 1378–82.
33. Sherman, Susan G., Yingkai Cheng, and Alexander H. Kral. 2007. “Prevalence and Correlates of Opiate Overdose Among Young Injection Drug Users in a Large U.S. City.” Drug and Alcohol Dependence 88 (2–3): 182–87.
34. StataCorp. 2011. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.
35. Stone, Cord. 2014, March 7. Personal e-mail correspondence with Cord Stone, Director of Behavioral Health, Evergreen Health Services, Buffalo, New York.
36. Taveira da Silva, Angelo M., J. Dias Souza, John A. Quest, F.D. Pagani, Joseph M. Moerschbaecher, A. Buller, Paul Hamosh, and Richard A. Gillis. 1983. “Central Nervous System Site of Action for the Respiratory Depressant Effect of Diacetylmorphine (heroin) in the Cat.” Journal of Clinical Investigation 72 (4): 1209–17.
37. Tracy, Melissa, Tinka Markham Piper, Danielle Ompad, Angela Bucciarelli, Phillip O. Coffin, David Vlahov, and Sandro Galea. 2005. “Circumstances of Witnessed Overdose in New York City: Implications for Intervention.” Drug and Alcohol Dependence 79: 181–90.
38. Trust for America's Health. 2013. “WONDER Online Database.” In Prescription Drug Abuse: Strategies to Stop the Epidemic in Trust for America's Health [Online]. http://healthyamericans.org/assets/files/TFAH2013RxDrugAbuseRpt16.pdf. Accessed November 5, 2015.
39. U.S. Department of Health and Human Services. 2015. Drugs@FDA: FDA Approved Drug Products [Online]. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&SearchTerm=NALOXONE. Accessed January 28, 2016.
40. Worthington, Nancy, Tinka Markham, Piper, Galeo, Sandro, & Rosenthal, David. 2006. “Opiate Users’ Knowledge about Overdose Prevention and Naloxone in New York City: A Focus Group.” Harm Reduction Journal 3 (19). http://www.harmreductionjournal.com/content/3/1/19